Ampac reopens Virginia site
US-based API manufacturer Ampac Fine Chemicals (AFC) has officially reopened the manufacturing operations of its AFC-Virginia facility at Petersburg, Virginia, in front of state and local dignitaries and other guests. This follows an extensive refurbishment, including technology and infrastructure upgrades.
The site now has 189 m3 of total capacity in multiple bays and a history of making both Schedule II controlled substances and highly potent APIs. AFC has since registered the site for controlled substance manufacture with the Drug Enforcement Agency. It expects to add over 110 new jobs to the site in the coming years.
Petersburg originally belonged to Boehringer Ingelheim and AFC acquired it from UniTao Pharmaceuticals in October 2016, when capacity was said to be over 300 m3, but the site was idle. The stated intention at the time was to use it to support cGMP production of intermediates and APIs at a time of rising demand in the US.
AFC, which was acquired by Korea’s SK Group last year, has other sites at Rancho Cordova and El Dorado, California, and LaPorte, Texas, which was also lying idle when AFC bought it in 2010. Rancho Cordova underwent a major expansion in 2016-17. Key specialities across these sites include hazardous and energetic chemistries and simulated moving bed chromatography.